A Multinational Retrospective Medical Record Review to Evaluate Utilisation Patterns of ADASUVE® (Staccato loxapine for inhalation) in Agitated Persons in Routine Clinical Care

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/9083
• EU PAS number:
  EUPAS8419
• Study ID:
  9083
• Official title and acronym:
  A Multinational Retrospective Medical Record Review to Evaluate Utilisation Patterns of ADASUVE® (Staccato loxapine for inhalation) in Agitated Persons in Routine Clinical Care
• DARWIN EU® study:
  No
• Study countries:
  Austria

  France

  Germany

  Romania

  Spain

  Sweden
• Study description:
  This multicentre, multinational, observational study conducted in Europe entails retrospective review of medical records of patients receiving ADASUVE® in real world settings.
• Study status:
  Planned

Research institutions and networks

Institutions

Alexza Pharmaceuticals

Study timelines

Date when funding contract was signed

Planned: 14/01/2014

Actual: 01/01/2014

Study start date

Planned: 31/03/2015

Date of final study report

Planned: 30/09/2016

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Alexza Pharmaceuticals, Inc.

Regulatory

• Was the study required by a regulatory body?:
  Yes